{'fraction_non_alphanumeric': 0.03164556962025317, 'fraction_numerical': 0.030942334739803096, 'mean_word_length': 5.133620689655173, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Benefit-Cost Analysis of Surra Control in Sumba Timur Nusa Tenggara Timur-Indonesia

The research is financed by Indonesian agricultural of quarantine agency, The Ministry of Agricultural Indonesia (Sponsoring information) Abstract The Surra control program in East Sumba conducted by the East Sumba government is considered effective in reducing morbidity and mortality, including the use of trypanocidal as curative treatment using diminazene aceturate and preventive treatment using isometamidium chloride. The purpose of this study was to analyze the cost benefits of the Surra control program in East Sumba (2012-2015). The Surra control program requires high costs, including relatively expensive drug prices, a cost-benefit analysis conducted to assess economic feasibility and the results can be a reference for determining further policies in controlling Surra. Economic evaluation using Benefit-cost Analysis uses 3 criteria net present value (NPV), benefit cost ratio (B / C), and internal rate of return (IRR). Our results show that the NPV is 1.488 billion IDR, the B / C ratio is 1.18 and the IRR is 50.1%, this result shows that the control program implemented during 2012 to 2015 in East Sumba is economically profitable and feasible to continue Keywords: Surra, Benefit cost analysis, Benefit cost ratio, Internal rate return, Net present value DOI : 10.7176/JNSR/9-12-08 Publication date :June 30 th 2019